Evolus Corp (EOLS): Rasio rega marang pendapatan
Evolus, Inc. (EOLS) is protected by stringent FDA controls and exclusive rights to neurotoxins. Flexible digital marketing helps the company effectively capture the beauty market, while the popularity of Jeuveau among younger demographics drives revenue growth. This GURU.Markets chart of the price/sales ratio helps avoid overpaying for the asset, while 1.50 captures the magnitude of this parameter.
Rincian analitis perusahaan Jeuveau (EOLS)
- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi bursa:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Evolus, Inc.|EOLS - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Evolus Corp|EOLS - Utang perusahaan|Rasio utang marang nilai buku Jeuveau|EOLS - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Evolus|Koefisien jangkoan perantara evolus.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
EOLS - Bathi resik|Bathi resik sing dikarepake Evolus, Inc.|EOLS - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Evolus Inc|EOLS - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Jeuveau|EOLS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Evolus|EOLS - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan evolus.com|EOLS - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Evolus, Inc.
- data total pendapatan lan volume dodolan:
Analisis fundamental perusahaan:evolus.com (EOLS)
Evolus, Inc. (EOLS) is aggressively expanding its presence in the neurotoxin segment, competing with industry leaders through affordable pricing and the digitalization of sales. By analyzing the company's P/S ratio dynamics, an investor assesses the market value of each unit of revenue, which allows for the timely identification of trend reversals and prevents overpaying for an overvalued asset or purchasing a fading business during a period of stagnant sales.
Perusahaan pesaing
HCA - Rega marang dodolan|Rasio rega marang pendapatan Tenet Healthcare Corporation THC|Fresenius Medical Care AG - Rasio rega marang pendapatan|SOLV: Kapitalisasi marang pendapatan|EHC - Multiplikator P/S|uhsinc.com (UHS) - Rasio rega marang pendapatan|DVA - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan RDNT|OPCH: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S SGRY|Koefisien rega marang pendapatan Premier Health|Rasio rega marang pendapatan National Vision Holdings EYE|PGNY: Rasio kapitalisasi marang pendapatan|Ardent Health Partners - Multiplikator P/S|Select Medical Corporation (SEM) - Kapitalisasi marang pendapatan|ASTH (Apollo Medical Holdings) - Kapitalisasi marang pendapatan|MD - Koefisien rega marang pendapatan|USPH (US Physical Therapy) - Multiplikator P/S|Rega marang dodolan pennantgroup.com PNTG|Rasio rega marang pendapatan Organogenesis (ORGO)|NUTX - Rega marang dodolan|Rasio rega marang pendapatan Auna Health AUNA|SBC Medical Group Holdings - Rasio rega marang pendapatan|CYH - Rasio rega marang pendapatan|Koefisien rega marang pendapatan The Beauty Health SKIN|MDWD (mediwound.com) - Kapitalisasi marang pendapatan|BTMD: Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan The Joint Corporation|DCGO: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S PIII|GANX - Rega marang dodolan|Multiplikator P/S EUDA (EUDA Health Holdings Limited)|Multiplikator P/S Basel Medical BMGL|CLGN: Kapitalisasi marang pendapatan|Cuprina Holdings Limited - Kapitalisasi marang volume dodolan|Concord Medical Services (CCM) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ashs.com|MRM (MEDIROM Healthcare Group) - Multiplikator P/S|Rega marang dodolan Avalon GloboCare Corporation ALBT|Rasio rega marang pendapatan DIH Holding US Inc. (DHAI)|Carmell Corp - Rasio kapitalisasi marang pendapatan|NewGenIvf Group Limited - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan ATIP (ATI Physical Therapy Inc.)|CareMax - Multiplikator P/S|Rega marang dodolan Kindly MD Inc|MODV (LogistiCare) - Kapitalisasi marang pendapatan|NVOS (Novo Integrated Sciences Corp) - Rasio rega marang pendapatan|Rasio rega marang pendapatan SunLink Health Systems Inc.|Rega marang dodolan imacholdings.comm BACK
